SEP 20, 2018 5:00 PM PDT

Chemotherapeutic Drugs Battle Antimalarial Drug Resistance

WRITTEN BY: Nouran Amin

Credit: Hindustan Times

According to the latest research published in the journal Nature Communications, researchers discovered that chemotherapeutic drugs can increase the effectiveness of the most powerful antimalarial drug: artemisinin.

In the battle against drug resistance and treating malaria, artemisinin was discovered to work through a "double whammy" attack on the deadly parasite responsible for malaria—thanks to researchers from the University of Melbourne and the Japanese pharmaceutical company Takeda.

Artemisinin works by damaging the proteins present in malaria parasites eventually clogging the parasite's waste disposal system: the proteasome. Resistance to artemisinin has developed in South-East Asia and it may reach Africa soon. Understanding the workings of artemisinin is crucial in fighting malaria, which claims the life of about 450,000 people annually.

Watch this short video about the anti-malarial drug, Artemisinin:

"The double whammy effect means that combining artemisinin with an anti-cancer drug that also targets the proteasome, complements the activity of artemisinin, and can restore activity against artemisinin-resistant parasites,” explains Professor Leann Tilley of the University of Melbourne. "The parasite's proteasome is like a shredder that chews up damaged or used-up proteins. Treating malaria parasites with artemisinin generates a lot of damaged proteins. Artemisinin and proteasome inhibitors thus can work together to jam the recycling system."

The clogging of the proteasome leads to protein accumulation marked as the “kiss of death” as these proteins eventually stress the parasite and causing cell death. Thus, the collaboration between University of Melbourne researchers and Takeda was to identify parasite-specific proteasome inhibitors in order to develop drugs needed to advance to clinical studies.” At Takeda, we are proud to contribute our expertise to help address critical global health problems. In this case, we were able to leverage our oncology research on the proteasome system and uncover a potential new way to treat malaria," explains Larry Dick, Director at Takeda.

"Electron microscope images of malaria parasites (blue )and chemical structure of artemisinin." Image Credit: Dr Eric Hanssen, University of Melbourne via Science Daily

"We are currently undertaking medicinal chemistry work to create novel analogs of human proteasome inhibitors that specifically inhibit the parasite proteasome,” Professor Tilley said. "We want a compound that can be administered orally and will last a long time in the bloodstream. If a suitable compound can be found, human trials could happen very soon."

Source: University of Melbourne, Nature Communications

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 05, 2020
Drug Discovery & Development
Fecal Transplants Could Restore Cognitive Function in the Elderly
OCT 05, 2020
Fecal Transplants Could Restore Cognitive Function in the Elderly
An international team of researchers has found that fecal transplants could one day be used to restore cognitive functio ...
NOV 01, 2020
Cannabis Sciences
Can Cannabis Treat ALS?
NOV 01, 2020
Can Cannabis Treat ALS?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative illness that damages motor neurons and leads to progressive m ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 08, 2020
Neuroscience
Psychedelic DMT Improves Memory by Neurogenesis
NOV 08, 2020
Psychedelic DMT Improves Memory by Neurogenesis
Researchers from the Complutense University of Madrid in Spain have found that dimethyltryptamine (DMT), the psychoactiv ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 26, 2020
Drug Discovery & Development
Sestrin Increases the Lifespan of Fruit Flies
NOV 26, 2020
Sestrin Increases the Lifespan of Fruit Flies
Reduced food intake, known as dietary restriction, leads to a longer lifespan in many animals and can improve health in ...
Loading Comments...